2009
DOI: 10.1021/jm8015987
|View full text |Cite
|
Sign up to set email alerts
|

Virtual Screening Approach for the Identification of New Rac1 Inhibitors

Abstract: Rac1 protein is implicated in several events of atherosclerotic plaque development and represents a new potential pharmacological target for cardiovascular diseases. In this paper we describe a pharmacophore virtual screening followed by molecular docking calculations leading to the identification of five new Rac1 inhibitors. These compounds were shown to be more effective than the reference compound NSC23766 in reducing the intracellular levels of Rac1-GTP, thus supporting this approach for the development of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
109
0
2

Year Published

2012
2012
2020
2020

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 95 publications
(112 citation statements)
references
References 17 publications
1
109
0
2
Order By: Relevance
“…Therefore, the unexpected antagonistic effect of NSC23766 at mAChRs in the concentration range required to substantially suppress Tiam1-and Trio-mediated Rac1 activation will clearly limit its potential as novel therapeutic agent. Our data also imply a need for consequent testing of newly found "Rac1 inhibitors" (Ferri et al, 2009;Montalvo-Ortiz et al, 2012) for mAChR antagonistic properties before pursuing them further in drug development.…”
Section: Discussionmentioning
confidence: 91%
“…Therefore, the unexpected antagonistic effect of NSC23766 at mAChRs in the concentration range required to substantially suppress Tiam1-and Trio-mediated Rac1 activation will clearly limit its potential as novel therapeutic agent. Our data also imply a need for consequent testing of newly found "Rac1 inhibitors" (Ferri et al, 2009;Montalvo-Ortiz et al, 2012) for mAChR antagonistic properties before pursuing them further in drug development.…”
Section: Discussionmentioning
confidence: 91%
“…The intracellular amount of Rac1-GTP and RhoA-GTP were determined by using the G-LISA assay as previously described (Cytoskeleton, Inc Denver, CO, USA) [23][24][25] . 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 11…”
Section: G-lisa Assay For Rac1 and Rhoamentioning
confidence: 99%
“…2 In particular, our group is currently interested in synthetic methodologies to achieve novel sulfonamide derivatives which have been found useful as potential inhibitors of protein Rac1. 3 For those reasons, in this paper we describe a facile and versatile synthetic method to obtain azacycloalkene-monosulfonyl-diamines from accessible starting materials.…”
Section: Introductionmentioning
confidence: 99%